NEW YORK, Feb. 14 /PRNewswire/ -- National Penn Bancshares Inc. (NASD: NPBC) will replace Bradley Pharmaceuticals Inc. (NYSE: BDY) in the S&P SmallCap 600 after the close of trading on Thursday, February 21, 2008. BDY is being acquired in a deal expected to close on or about that date, pending final approvals.
Standard & Poor's will monitor this transaction, and post any relevant updates on its website: http://www.standardandpoors.com.
National Penn Bancshares provides commercial banking services in
southeastern Pennsylvania and Maryland. Headquartered in Boyertown, PA, the
company will be added to the S&P SmallCap 600 GICS (Global Industry
Classification Standard) Regional Banks Sub-Industry index.
Following is a summary of the change:
S&P SMALLCAP 600 INDEX - February 21, 2008
COMPANY GICS ECONOMIC SECTOR GICS SUB-INDUSTRY
ADDED National Penn Financials Regional Banks
Bancshares
DELETED Bradley Health Care Pharmaceuticals
Pharmaceuticals
Additions to and deletions from an S&P equity index do not in any way reflect an opinion on the investment merits of the companies concerned.
About Standard & Poor's
Standard & Poor's, a division of The McGraw-Hill Companies (NYSE: MHP),
is the world's foremost provider of financial market intelligence,
including independent credit ratings, in
'/>"/>
| SOURCE Standard & Poor's Copyright©2008 PR Newswire. All rights reserved |